These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2729934)

  • 1. Safety and tolerance of ocular administration of recombinant alpha interferon.
    Turner RB; Durcan FJ; Albrecht JK; Crandall AS
    Antimicrob Agents Chemother; 1989 Mar; 33(3):396-7. PubMed ID: 2729934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A).
    Hayden FG; Mills SE; Innes DJ; Darragh A; Just M; Linder-Chiccolunghi SN; Gauci L
    Antiviral Res; 1987 Oct; 8(3):139-49. PubMed ID: 3426184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers.
    Samo TC; Greenberg SB; Couch RB; Quarles J; Johnson PE; Hook S; Harmon MW
    J Infect Dis; 1983 Sep; 148(3):535-42. PubMed ID: 6619578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasally applied recombinant leukocyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose.
    Samo TC; Greenberg SB; Palmer JM; Couch RB; Harmon MW; Johnson PE
    J Infect Dis; 1984 Aug; 150(2):181-8. PubMed ID: 6381611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tolerance and histopathologic effects of long-term administration of intranasal interferon-alpha 2.
    Hayden FG; Mills SE; Johns ME
    J Infect Dis; 1983 Nov; 148(5):914-21. PubMed ID: 6355321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha 2 in natural respiratory viral infections.
    Hayden FG; Gwaltney JM; Johns ME
    Antiviral Res; 1985 Apr; 5(2):111-6. PubMed ID: 4015079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmucosal absorption of recombinant human interferon-alpha B/D hybrid in the rat and rabbit.
    Bayley D; Temple C; Clay V; Steward A; Lowther N
    J Pharm Pharmacol; 1995 Sep; 47(9):721-4. PubMed ID: 8583382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration].
    Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL
    Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of clinical trials and the prospects of using the Soviet preparation of human recombinant interferon alpha-2 (reaferon) in medical practice].
    Kalinin IuT; Vorob'ev AA; Bumialis VV; Denisov LA; Parfenov VV; Klenova AV; Ianulaĭtis AA; Ershov FI; Marchenko VI; Malinovskaia VV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):61-7. PubMed ID: 2256404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
    Hayden FG; Kaiser DL; Albrecht JK
    Antimicrob Agents Chemother; 1988 Feb; 32(2):224-30. PubMed ID: 2834996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal tolerance and histopathologic effects of a novel synthetic interferon, rIFN-alpha Con1.
    Hayden FG; Innes DJ; Mills SE; Levine PA
    Antiviral Res; 1988 Dec; 10(4-5):225-34. PubMed ID: 2852485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
    Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
    Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
    J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans.
    Treanor JJ; Betts RF; Erb SM; Roth FK; Dolin R
    J Infect Dis; 1987 Aug; 156(2):379-83. PubMed ID: 3598236
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
    Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
    Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.